pentane : dichloromethane, 5 : 1) and obtained as a colourless
oil.
(m, 28H, Ar), 5.03 (s, 2H, H1a/H1b), 4.69 (d, J = 14, 2H, BnHa),
4.54 (d, J = 14, 2H, BnHb), 3.66 (s, 6H, OMe), 0.48 (s, 6H,
Me2C<). 13C-NMR (CDCl3): d = 156.3 (Ar-1), 147.2 (Ar-2),
142.6 (Ph-), 129,5, 128.8, 128.2, 127.9, 127.6 127.5, 127.3, 127.2,
127.1 (Ar, Ph), 120.7 (Ar-4), 113.7 (Me2C<), 109.8 (Ar-3),
82.5 (Ph2C<), 81.2 (C1a/C1b), 61.0 (PhCH2-), 55.4 (OMe), 27.3
(Me2C<). IR (NaCl)/cm−1: m = 3059 (Ar C–H sp2), 2992, 2935,
2836 (C–H sp3), 1603, 1590, 1493 (Ar C–H sp2). MS(ES): calc.
for (M + Na) = 789.2859, found 789.5275.
General procedure for aldehydes (B)
Into a 7 ml sample vial equipped with a septum, to a solution
of ca. 100 mg aldehyde in 4 ml acetonitrile under nitrogen,
iodobenzene diacetate (1.5 eq., with respect to aldehyde) was
added and stirred until complete dissolution. The mixture was
then cooled to 0 ◦C on an ice bath and TMSN3 (2.5 eq.) was
added dropwise to the mixture. After the resulting evolution
of gas was completed, the reaction mixture was allowed to
reach room temperature and the reaction was followed by TLC
showing the formation of acyl azide. The vial was then heated
to 83 ◦C for ca. 30 min to obtain the Curtius rearrangement
followed by formation of carbamoyl azide. The reaction mixture
was concentrated in vacuo and the product was isolated by
column chromatography (pentane for removing the iodobenzene
and than pentane : ethyl acetate, 10 : 1).
6-(a-Azido-2-methoxybenzyloxy)-6-(2-methoxybenzyloxy)-2,2-
dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]-
dioxasilepine (14). Prepared from 13 using general procedure
A. Colorless oil. Yield: 27 mg (51%). Diastereomeric ratio
1
1 : 3. H-NMR (CDCl3): d = 6.6–7.6 (m, 28H, Ar), 6.0/6.1
(s, 1H, N3-C-H/N3–C–Hꢀ), 5.04 (m, 2H, H1, H2), 4.72/4.69
ꢀ
(d, J = 13.6, 1H, BnHa/ BnHa ), 4.55/4.53 (d, J = 13.6, 1H,
ꢀ
BnHb/BnHb ), 3.66, 3.67, 3.68, 3.69 (s, 6H, –OMe), 0.43, 0.47,
0.48, 0.49 (s, 6H, Me2C<). 13C-NMR (CDCl3): d = 156.1
(Ar-1), 146.7 (Ar-2), 142.3 (Ph-), 130.0, 129.4, 129.3 128.3,
128.2 128.0, 127.9 127.5, 127.4, 127.3, 127.3, 127.1, 127.1 (Ar,
Ph), 120.7 (Ar-4), 113.8 (Me2C<), 110.3 (Ar-3), 109.7 (C–N3),
82.9/81.9 (Ph2C<), 81.1/81.0 (C1a/C1b), 61.3/61.1 (PhCH2–),
55.6/55.3 (OMe), 27.2 (Me2C<). IR (NaCl)/cm−1: m = 2105
(–N3), 1602, 1559, 1492 (Ar C–H sp2). MS(ES): calc. for (M +
Na) = 830.2874, found 830.1154.
a-Azidobenzyl methylether (2)15. Prepared from commer-
cially available 1 using general procedure A. Colorless oil. Yield:
123 mg (88%).
(R,S)-a-Azido-benzyl 2-O-acetyl-3,4-O-isopropylidene-b-D-
arabinopyranoside (4)15. Prepared from 318 using general
procedure A. Colorless oil. Yield: 75 mg (71%).
a-Azidobenzyl 3-trimethylsilanoxypropyl ether (16). Pre-
3-(Azido-phenyl-methoxy)-8-aza-bicyclo[3.2.1]octane-8-carb-
oxylic acid tert-butyl ester (6)16. Prepared from 516 using
general procedure A. Clear colourless oil. Yield: 89 mg (79%).
a-Azidobenzyl benzyl ether (8)19. Prepared from commer-
cially available 7 using general procedure A. Colourless oil.
Yield: 120 mg (89%).
pared from 1521 using general procedure A. Colorless oil. Yield:
1
102 mg (82%). H-NMR (CDCl3): d = 7.36–7.47 (m, 5H, Ar),
5.43 (s, 1H, N3–C–H), 3.96 (m, 1H, H1a), 3.65–3.75 (m, 3H, H1b,
H3), 1.91 (m, 2H, H2), 0.11 (s, 9H, OTMS). 13C-NMR (CDCl3):
d = 137.8(Ar-1), 129.2(H3), 128.9(H4), 126.6(H2), 93.2 (>C–N3),
66.4 (C3), 59.7 (C1), 33.1 (C2), 0.0(TMS). IR (NaCl)/cm−1: m =
2956 (C–H sp3), 2105(vs) (N3) MS(ES): calc. for (M + Na) =
302.1322, found 302.1301.
a-Azidophthalan (10). Prepared from commercially avail-
able 9 using general procedure A. Colorless oil. Yield: 67 mg
1
(50%). H-NMR (CDCl3): d = 7.32–7.56 (m, 4H, Ar), 6.34 (s,
General procedure for preparation of substituted dibenzyl ethers
(21)
1H, N3–C–H), 5.33 (d, J = 12.4, 1H, Ar–CHa–O), 5.13 (d, J =
12.4, 1H, Ar–CHb-O). 13C-NMR (CDCl3): d = 139.3 (Ar-2),
136.4 (Ar-1), 129.8 (Ar-6), 128.3 (Ar-3), 122.7 (Ar-4). 121.4 (Ar-
5), 96.0 (C–N3), 73.9 (PhCH2). IR (NaCl)/cm−1: m = 3081, 3051
(Ar C–H sp2), 2926, 2875 (C–H sp3), 2099(vs) (N3).
Substituted benzyl alcohol (1 eq.) was dissolved in dry DMF
under nitrogen atmosphere. The mixture was cooled on an ice
bath and pre-washed NaH (2 eq.) was slowly added. After
stirring for 30 min, benzyl bromide (1.2 eq.) was added slowly
by syringe, and the mixture was allowed to come to room
temperature. After stirring overnight, the reaction was quenched
with water and extracted with ether. The combined organic
fractions were washed with brine, dried (MgSO4), concentrated
in vacuo and purified by flash chromatography (DCM : pentane,
1 : 3) to give colorless to pale yellow oils.
(a-Azido-(2-methoxybenzyl)oxy)tris(((1R,2S,5R)-2-isopropyl-
5-methylcyclohexyl)oxy)silane (12). Prepared from 1120 using
general procedure A. Colorless oil. Yield: 89 mg (84%).
1H-NMR(CDCl3): d = 7.58 (dt, J = 1.6, J = 6.1, 1H, Ar),
7.31 (tt, J = 2.1, J = 7.8, 1H, Ar), 6.98 (dt, J = 3.4, J = 7.3,
1H, Ar), 6.88 (dd, J = 1.8, J = 8.0, 1H, Ar), 6.38/6.36 (s,
1H, BnH/BnHꢀ), 3.86/3.85 (s, 3H, OMe/OMeꢀ), 3.71 (m, 3H,
H1a), 2.24 (m, 3H, H7), 2.1/2.0 (bd, J = 11.8, 2H, H2a, H2aꢀ),
1.55–1.65 (m, 6H, H6), 1.33 (m, 3H, H4e), 1.20 (m, 3H, H3e), 1.04
(m, 3H, H5a), 0.84–1.0 (m, 24H, Me2C–, H3a, H4a), 0.70/0.78
(d, 3H, Me/Meꢀ). 13C-NMR (CDCl3): d = 156.0 (Ar-1), 129.9
(Ar-5), 127.8 (Ar-2), 126.4 (Ar-3), 120.5 (Ar-4), 110.4 (Ar-6),
81.2 (C-N3), 74.0 (C1), 55.5 (OMe), 49.8/49.7 (C2), 44.9 (C4),
34.6, 31.8, 25.5, 22.8, 22.3, 21.3, 15.8/15.7 (C3, C5, C6, Me,
Me2C, Me2C). IR (NaCl)/cm−1: m = 2954, 2923, 2870 (C–H
sp3), 2103(vs) (–N3), 1604, 1592, 1494 (Ar C–H sp2). MS(ES):
calc. for (M + Na) = 694.5656, found 694.5656.
a,a-D2 dibenzyl ether (18) was prepared according to literature
procedures.26
Selectivity and isotope effect experiments with dibenzylethers
(18/21)
General procedure for PhI(OAc)2–TMSN3
Into a 7 ml sample vial equipped with a septum, ca. 100 mg
of benzyl ether was dissolved in 4 ml acetonitrile under a
nitrogen atmosphere. 1.5 eq. of iodobenzene diacetate (with
respect to ether) was added and the mixture was stirred until
complete dissolution. TMSN3 (2 eq.) was then added dropwise
by syringe. After the gas had finished developing, the reaction
mixture was concentrated in vacuo to give a crude oil containing
the two products and iodobenzene. The ratio of products was
determined by comparing integrals in 1H-NMR.
(6,6-bis(2-Methoxybenzyloxy)-2,2-dimethyl-4,4,8,8-tetra-
phenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxasilepine
(13).
Freshly distilled tetrachlorosilane (57 ll, 0.5 mmol) was added
to a solution of R,R-TADDOL (0.233 mg, 0.5 mmol) in 20 ml
of dry toluene under a nitrogen atmosphere. Pyridine (0.12 ml,
1.5 mmol) was then added and the reaction mixture was stirred
overnight. After this, o-methoxy-benzylic alcohol (0.13 ml, 1
mmol) was added. The mixture was stirred overnight, filtered
through celite and concentrated in vacuo. The product was
purified by flash chromatography (pentane : ether 10 : 1 to 1 : 1)
as a white solid (0.213 g, 56%). 1H-NMR (CDCl3): d = 6.6–7.6
General procedure for IN3
In a 7 ml vial equipped with a septum, ICl (2 eq.) was dissolved
in 4 ml ◦dry acetonitrile under nitrogen atmosphere and cooled
to −10 C. Sodium azide (2.3 eq.) was added and the mixture
8 2 0
O r g . B i o m o l . C h e m . , 2 0 0 5 , 3 , 8 1 6 – 8 2 2